Collector
Giriş Yap
Celsius Stock Stabilizes: Will Insider Buying Stop The Downward Trend? | Collector
Celsius Stock Stabilizes: Will Insider Buying Stop The Downward Trend?
Benzinga

Celsius Stock Stabilizes: Will Insider Buying Stop The Downward Trend?

Celsius Holdings is marginally higher in Tuesday's premarket as traders lean into a risk-on tape and focus on insider-buying signals. Importance Rank: 2 read more

Go to News Site
Google Play Google Play App Store App Store
These ETFs surged thanks to early SpaceX stakes. W
MarketWatch
These ETFs surged thanks to early SpaceX stakes. What happens to them after the IPO?
 Schwab's Sonders Sees 'Red Flags,' Possible Inflat
Bloomberg Markets
Schwab's Sonders Sees 'Red Flags,' Possible Inflationary Boom
 Treasury Market Signals Rates Need to Be Higher
Bloomberg Markets
Treasury Market Signals Rates Need to Be Higher
 JPMorgan Chase plans autonomous AI agents for 2026
Yahoo Finance
JPMorgan Chase plans autonomous AI agents for 2026
 JPMorgan Chase is planning to deploy longer-runnin
Quartz
JPMorgan Chase is planning to deploy longer-running autonomous AI agents in 2026
 J.M. Smucker Stock Is Having Its Best Day Since 20
Yahoo Finance
J.M. Smucker Stock Is Having Its Best Day Since 2008 After Solid Earnings
Benzinga
Apple To Rally More Than 19%? Here Are 10 Top Analyst Foreca
Benzinga
Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday
 FuelCell Energy Stock Is Surging Tuesday: What's Driving The
Benzinga
FuelCell Energy Stock Is Surging Tuesday: What's Driving The Move?
 2026 FIFA World Cup Fever Could Trigger A $30 Billion Produc
Benzinga
2026 FIFA World Cup Fever Could Trigger A $30 Billion Productivity Hit For US Employers
 Why Is Nocera Stock Trading Higher Today?
Benzinga
Why Is Nocera Stock Trading Higher Today?
 Nebius Launches AI Robotics Living Lab With NVIDIA Robotics
Benzinga
Nebius Launches AI Robotics Living Lab With NVIDIA Robotics Program
 Academy Sports Raises Outlook, But Warns Shoppers Will Stay
Benzinga
Academy Sports Raises Outlook, But Warns Shoppers Will Stay Squeezed Through 2026
 Redwire Stock Falls After Company Launches $500 Million ATM
Benzinga
Redwire Stock Falls After Company Launches $500 Million ATM Equity Offering
 Oracle Stock In Focus Ahead of Q4 Earnings — Four Consecutiv
Benzinga
Oracle Stock In Focus Ahead of Q4 Earnings — Four Consecutive EPS Beats In The Rearview
 MANGOS Is The New Magnificent Seven — And Half Of It Hasn't
Benzinga
MANGOS Is The New Magnificent Seven — And Half Of It Hasn't Gone Public Yet
 What's Going On With Stellantis Stock Before Tuesday's Openi
Benzinga
What's Going On With Stellantis Stock Before Tuesday's Opening Bell?
 12 Communication Services Stocks Moving In Tuesday's Pre-Mar
Benzinga
12 Communication Services Stocks Moving In Tuesday's Pre-Market Session
 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 12 Industrials Stocks Moving In Tuesday's Pre-Market Session
Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
 12 Information Technology Stocks Moving In Tuesday's Pre-Mar
Benzinga
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
 Paramount Accuses Netflix Of Waging 'Scorched-Earth Campaign
Benzinga
Paramount Accuses Netflix Of Waging 'Scorched-Earth Campaign' To Derail Warner Bros. Discovery Deal: Report
 How To Earn $500 A Month From Oracle Stock Ahead Of Q4 Earni
Benzinga
How To Earn $500 A Month From Oracle Stock Ahead Of Q4 Earnings
 Uranium Energy Reports Q3 Results With Wider EPS Loss, Share
Benzinga
Uranium Energy Reports Q3 Results With Wider EPS Loss, Shares Slide
 Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Bio
Benzinga
Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Biosciences, Perrigo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 Wall Street's Most Accurate Analysts Spotlight On 3 Risk Off
Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields
 GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.
Benzinga
GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent